Matrix metalloproteinase 2 (MMP-2) is a proteolytic enzyme implicated in motility, differentiation and regeneration of skeletal muscle fibers through processing of extracellular substrates. Although MMP-2 has been found to be localized intracellularly in cardiomyocytes where the enzyme is thought to contribute to post-ischemic loss of contractility, little is known about intracellular MMP-2 activity in skeletal muscle fibers. In the present study we demonstrate intracellular MMP-2 in normal skeletal muscle by immunohistochemical staining. Immunogold electron microscopic analyses indicated that the enzyme was concentrated in Z-lines of the sarcomers, in the nuclear membrane and in mitochondria. By use of in situ zymography, we found that gelatinolytic activity in muscle fibers was colocalized with immunofluorecent staining for MMP-2. Staining for MMP-9, the other member of the gelatinase group of the MMPs, was negative. The broad-spectrum metalloprotease inhibitor EDTA and the selective gelatinase inhibitor CTT2, but not the cysteine inhibitor E64, strongly reduced the gelatinolytic activity. The intracellular gelatinolytic activity was much more prominent in fast twitch type II fibers than in slow twitch type I fibers, and there was a decrease in intracellular gelatinolytic activity and MMP-2 expression in muscles from mice exposed to high intensity interval training. Together our results indicate that MMP-2 is part of the intracellular proteolytic network in normal skeletal muscle, especially in fast twitch type II fibers. Further, the results suggest that intracellular MMP-2 in skeletal muscle fibers is active during normal homeostasis, and affected by level of physical activity.
Introduction
Matrix metalloproteinase 2 (MMP-2), also called gelatinase A, is produced by skeletal muscle fibers during homeostasis and is up-regulated by various physiological and pathological stimuli (Lewis et al., 2000; Carmeli et al., 2005; Carmeli et al., 2010; Dahiya et al., 2011; Alameddine, 2012) . Through remodeling of the extracellular matrix (ECM) and by activation of signaling molecules the enzyme can affect motility, differentiation and regeneration of the myofibers (Chen and Li, 2009 ). The enzyme is also reported to be involved in the pathogenesis of muscular dystrophy and atrophy, though the precise mode of action is not well characterized (Fukushima et al., 2007; Kumar and Bhatnagar, 2010; Miyazaki et al., 2011) . Although MMP-2 has an N-terminal signal peptide that direct the enzyme for secretion, recent research suggests that it is an inefficient signal causing retention of a substantial portion of the enzyme within cells (Ali et al., 2012) . It is a major gelatinolytic enzyme, but can also degrade a number of other matrix and non-matrix substrates (Visse and Nagase, 2003; Rodriguez et al., 2010; Ali et al., 2011) . Previously, extracellular functions have been the major focus in MMP-2 research, but recently intracellular variants along with several intracellular putative substrates of this MMP has been reported in some cell types (Cauwe and Opdenakker, 2010; Ali et al., 2011; Hadler-Olsen et al., 2011a) . Many of the intracellular substrates have been detected by proteomic analyses, and the precise localization, activity and functions of intracellular MMP-2 is to a large extent unknown. In cardiomyocytes intracellular MMP-2 activity is believed to contribute to the reversible loss of contractile function after acute stress, such as ischemia-reperfusion. In vitro and in vivo studies suggested that this was due to MMP-2 cleavage of troponin I, a central protein in the regulation of muscle contraction, as well as the cytoskeletal protein α-actinin (Bolli and Marban, 1999; Wang et al., 2002; Sung et al., 2007b) . Other possible MMP-2 substrates in cardiomyocytes include desmin, myosin light chain-1 and titin (Ali et al., 2011) . Nuclear MMP-2 activity has been associated with apoptosis in several cell types such as in brain neuronal cells, pulmonary endothelial cells and cardiomyocytes (Kwan et al., 2004; Ruta et al., 2009; Yang et al., 2010; Hill et al., 2012) .
Due to the similarity in structure and function of cardiac and skeletal muscles, we hypothesised that MMP-2 could be intracellularly localized and active also in skeletal muscle fibers. As MMP-2 is expressed in skeletal muscle during homeostasis (Lewis et al., 2000) , we wanted to study putative intracellular MMP-2 localization and activity in normal, healthy muscle fibers. By immunohistochemistry and immunogold analyses we demonstrated MMP-2 intracellularly in compartments not associated with the biosynthetic and secretory pathway in various groups of skeletal muscles in both mice and human. In situ zymography is a method to detect enzyme activity in a tissue section. A quenched, fluorescence-labeled substrate is put on top of a tissue section, and this substrate will be cleaved and fluorescence emitted in areas of the tissue where enzymes with specificity towards the chosen substrate are localized and active, in a time and dose-dependent manner. As sectioning will expose the interior of the vast majority of the cells in the tissue, no permeabilistaion is needed to study intracellular enzymes.
By in situ gelatin zymography combined with specific inhibitors and immunofluorescent MMP-2 staining we demonstrated that MMP-2 was active inside the muscle fibers. ATPase staining revealed that the activity was much more prominent in fast twitch type II fibers than in slow twitch type I fibers. Muscles from mice exposed to high intensity interval training showed decreased intracellular MMP-2 expression and gelatinolytic activity compared to their untrained littermates. Taken together our results demonstrate that MMP-2 is intracellularly localized and active inside skeletal muscle fibers during normal homeostasis. The expression and activity of the enzyme is most prominent in fast twitch type II fibers and affected by physical activity, but the precise role of the enzyme and the underlying regulatory mechanisms can so far only be speculated.
Materials and Methods

Cell culturing
The myoblast C2C12 cell line was purchased from Sigma-Aldricht (Sigma-Aldich, Steinheim, Germany). The cells were maintained in DMEM containing 4.5 g/L glucose (Sigma-Aldricht) and supplemented with 10 % FBS (V/V) (Sigma-Aldricht) in a humidified atmosphere of 5% CO 2 at 37 ̊ C. 200 000 cells were seeded in 12-well plates, and allowed to attach for 6 hours before changing to a differentiation medium of DMEM containing 4.5 g/L glucose supplemented with 3 % horse serum (Sigma-Aldricht). The cells were allowed to differentiate into myocytes for six days before serum-free DMEM was added (1ml/well) after PBS rinsing. Conditioned, serum free medium was harvested after 48 hours, and added HEPES and CaCl 2 to a final concentration of 0.1M and 0.01M respectively. Detached cells were removed by centrifugation at 1500 x g for 5 minutes at 4 ̊ C, and the supernatant was stored at -70 ̊ C until use. After the medium was harvested, cells were washed three times with PBS before cell lysates were prepared in 200 µl ice-cold lysisbuffer with proteinase inhibitor (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% Triton-X 100, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM CaCl 2 -2H 2 O, Sigmafast proteinase inhibitor cocktail, EDTA free). The cells were scraped, and the lysates collected, sonicated at 4 ̊ C in a BioRuptor Sonicator (Diagenode s.a, Liege, Belgum) and stored at -70 ̊ C. Protein content was determined using a Direct Detect Spectrometer (Millipore Corporation, Billerica, MA).
Tissue samples
Muscle tissue from the gastrocnemius muscle was harvested from 18 weeks old C57BL/6J male mice (Charles River Laboratories, Wilmington, USA). The mice were divided into two groups each containing five mice; one which had a normal cage activity (control) and the other where the mice were subjected to five consecutive days of high intensity tread mill running once a day for 60 minutes as previously described (Hafstad et al., 2011) . The mice were sacrificed and the gastrocnemius muscle, which contains a mixture of slow twitch and fast twitch muscle fibers were isolated. For mice subjected to high intensity training, the muscles were isolated within minutes after the last round of training. From three untrained mice, samples of the gastrocnemius muscle were also put in Allprotect tissue reagent (Qiagen, Hilden, Germany) for subsequent homogenization and protein extraction. In order to study MMP-2 in muscles from different locations, tongues were harvested from the untrained mice. unspecific staining was blocked with 0.8 % bovine serum albumin and 0.1 % gelatin from cold water fish skin (Sigma-Aldich, Steinheim, Germany). Gold conjugated antirabbit antibodies (10 nm) were used for detection (CMC, Utrecht, Netherlands).
Sections where the primary antibody was omitted were used as negative controls. The specificity of the antibodies has previously been validated by immunogold staining of cell lines expressing variable amounts of MMP-2 (Solli et al., 2013) . Immunogold labelling was studied in a JEOL JEM-1010 transmission electron microscope (JEOL Ltd.
Tokyo, Japan) equipped with a Morada digital camera (Olympus Corporation, Hamburg, Germany).
ATPase activity was detected in three different unfixed human samples of the vastus lateralis or biceps muscle at high pH (9.4) and low pH (4.5) according to standard procedures (Engel and Tice, 1966) .
In situ zymography
Gelatinolytic activity was localized by in situ zymography on five parallel samples of ZBFfixed gastrocnemius (from mouse) and tongue (from human and mouse) muscle samples, as well as on three unfixed human muscle samples from the biceps and vastus lateralis muscle as described earlier (Hadler-Olsen et al., 2010) . To verify the contribution of metalloproteinases, 20 mM EDTA was added to the substrate in control sections. As EDTA is a broad spectrum metalloproteinase inhibitor, the selective gelatinase (MMP-2 and MMP-9) inhibitor CTT2 (Pirila et al., 2001; Heikkila et al., 2006) was also used in a 100 µM concentration to demonstrate the contribution of MMP-2 to the gelatinolytic activity. Cysteine proteases are known to be major intracellular enzymes; therefore 10 ng/ml of the cysteine protease inhibitor E-64 (Sigma-Aldirich, Steinheim, Germany) was added to other control sections to evaluate the contribution of such enzymes to the intracellular gelatinolytic activity. The inhibitors CTT2 and E64, applied in the in situ zymography, were tested for quenching, using 4 µg/ml FITC-labeled gelatin (Molecular Probes, Eugene, OR) in the presence or absence of 100 µM CTT2 or 10µM E64, in the in situ zymography assay buffer. The fluorescence was determined in a LS50 B Luminescence Spectrometer (Perkin Elmer, Waltham, MA), with excitation wavelength of 490nm, emission wavelength of 520nm and slit width of 10 nm. Neither of the inhibitors could be regarded as quenchers as the fluorescence of the FITC-labeled gelatin was reduced by less than 0.5%.
The level of auto-fluorescence in the tissue was assessed by incubating control sections at -20˚C. For some sections, in situ zymography was followed by immunofluorescent detection of MMP-2 as described in the previous section. Fluorescence was studied using a Leica TSC SP5 confocal laser microscope with Leica Application Suite Advanced
Fluorescence software (Leica, Wetzlar, Germany).
SDS-PAGE gelatin zymography and real-time reverse zymography
To verify presence of MMP-2 in skeletal muscle by an antibody-independent technique, we also performed SDS-PAGE gelatin zymography on tissue extracts of gastrocnemius muscles from three parallel untrained mice as well as on cell lysates and serum-free conditioned medium of the murine myoblast cell line C2C12. The muscle tissue that was used for the extraction had been stored in Allprotect tissue reagent (Qiagen, Hilden, Germany) at -70 C until use. Before protein extraction, the Allprotect tissue reagent was rinsed off by PBS, and tissue samples were homogenised as previously described (Hadler-Olsen et al., 2011b) . The SDS-PAGE gelatin zymography was with gels containing 0.1% (w/v) gelatin and 4% and 7.5% (w/v) polyacrylamide in the stacking and separating gels, respectively performed (Hadler-Olsen et al., 2010) . Gelatinolytic activity was evident as cleared regions. As molecular weight standard human pro-MMP-9 dimer (225 kDa), pro-and processed MMP-9 monomer (92 kDa and 88kDa respectively) and pro-and processed human MMP-2 (72 kDa and 62 kDa respectively) was used. To evaluate the enzyme classes responsible for the observed gelatinolytic activity, two parallel gels were run. One was washed and incubated in buffers containing 10 mM EDTA, a metalloproteinase inhibitor, and the other in buffers without inhibitors (control).
In addition, to assess for inhibitors of gelatinolytic enzymes in muscle, the same samples from muscle tissue and myoblast cells were subjected to real-time reverse SDS-PAGE zymography, as previously described (Mathisen et al., 2003) . In brief, gels were prepared as for the SDS-PAGE gelatin zymography except that the separating gels contained 13% (w/v) polyacrylamide, 0.1 % 2-methoxy-2,4-diphenyl-3(2H)-furanone (MDPF)-labeled gelatin and conditioned medium from the THP-1 monocyte cell line which contains MMP-9 and TIMP-1. This medium was also used as a molecular weight standard. The gel was pre-run for 1 hour before the samples were loaded. During incubation 37 C, the gels were observed every 30 th minute under UV light until a clear contrast between the fluorescent inhibitor bands and the rest of the darkened gel had developed, and photographs were taken.
Mass spectrometry
To identify unknown gelatinolytic inhibitors detected by reverse SDS-PAGE substrate zymography, muscle tissue extract, C2C12 serum-free conditioned medium and cell lysate were subjected to non-reducing SDS-PAGE (NuPAGE Novex 4-12% Bis-Tris gels, Invitrogen, Carlsbad, CA). The gel was stained with Imperial Protein Stain (Thermo Scientific, Rockford, IL), and all defined protein bands with masses between 30 and 10 kDa were cut out. Additionally, bands with masses between 80-60 kDa were cut out. The bands were subjected to mass spectrometric analyses as described in Supplementary file.
Quantification and statistics
Volocity 3D Image Analysis Software (Perkin Elmer Inc., Waltham, MA) was used for quantification of the fluorescence intensity representing the in situ gelatinolytic activity or MMP-2 staining in muscle fibres from trained and normal control mice. Separating the fiber types was done manually in the Velocity Software using the freehand ROI tool.
Areas of the sections where the tissue was disrupted in any way was excluded, otherwise all intact and focused cross sectioned fibers in the field were measured. The strongly fluorescent region in the periphery of the fibers, probably representing the sarcolemma, was included in the quantification. The quantification gives a value of average fluorescence per area in each fiber type. Based on the results from the ATPase and in situ gelatin zymography results described in the result section, fibers with little gelatinolytic activity were interpreted as type I fibers and fibers with strong gelatinolytic activity as type II. The images used were of 20x magnification, and 3-4 different images from one sample provided areas from the whole section to be analysed. 
Results
Intracellular MMP-2 localization and activity in skeletal muscle fibers
To assess intracellular MMP-2 localization in skeletal muscle tissue, tissue samples from different muscle groups in mice and humans were immunohistochemically stained for MMP-2. Staining pattern was similar in all muscles stained both in mice ( Figure 1A and B, Figure 4 C and D (immunofluorescence)) and humans (Supplementary file Figure S1 A and B). In longitudinally cut muscle fibers, a cross-striated staining pattern as well as staining of the nuclear membranes were seen in many myocytes ( Figure 1A , S1A).The staining intensity varied somewhat between individual muscle fibers within a bundle. Cross sectioned muscle fibers also showed variable staining intensity of adjacent muscle fibers ( Figure 1B , S1B). A slightly stronger staining was observed in the periphery of many myofibers which may correspond to the endomysium, the sarcolemma and/or mitochondria which are often found in large numbers in the periphery of muscle fibers ( Figure 1B ). Negative control sections did not reveal any staining (Supplementary file Figure S1C ). MMP-9/gelatinase B, the other member of the MMP gelatinase group, was not detected in any of the skeletal muscle fibers (Supplementary file, Figure S1D (mouse) and S1E (Human)).
To further determine the intracellular localization of MMP-2 in the skeletal myofibers, immunogold electron microscopic analyses were performed on sections of the gastrocnemius muscle of mice. This revealed that in many fibers, MMP-2 was concentrated but not exclusively seen in the Z-bands ( Figure 1C) . In cross sections, MMP-2 could be detected in the periphery of the myofibrils, probably in the sarcoplasmic reticulum or in T-tubuli ( Figure   1D ). MMP-2 labeling was also observed in mitochondria ( Figure 1E ) as well as along the nuclear membrane ( Figure 1F ) and some scattered labeling throughout the muscle in unspecified compartments. Negative control sections did not reveal any labeling (Supplementary file Figure S1F ).
To verify presence of MMP-2 in muscle by an antibody independent method, which would also detect all other gelatinolytic enzymes in the muscles, tissue extracts of the gastrocnemius muscle from untrained mice as well as serum-free conditioned medium and cell lysate of the murine myoblast cell line C2C12 were subjected to SDS-PAGE gelatin zymgraphy. The zymography gels revealed strong gelatinolytic bands at 72 kDa, corresponding to the mass of MMP-2, from all samples (Figure 2a) , as well as a bands of about 75 kDa of unknown nature.
Lanes loaded with C2C12 serum-free, conditioned medium and cell lysate also showed gelatinolytic bands corresponding to processed MMP-2 (about 65 and 60 kDa). Some of the lanes loaded with muscle extracts revealed a diffuse band of about 110 kDa which may correspond to mouse MMP-9, reported to be somewhat larger than human due to more extensive glycosylation (Masure et al., 1997) . In gels where EDTA was added to the washing and incubation buffer, all bands disappeared, confirming that the gelatinolytic bands were produced by metalloproteases (Figure 2b ). Mass spectrometry confirmed presence of MMP-2 and also detected MMP-14, MMP-23 and MMP-24 in C2C12 cell lysate (data not shown).
To investigate presence of inhibitors of gelatinolytic enzymes in muscles, the same samples were subjected to real-time reverse gelatin zymography, using MDPF-labeled gelatin in the gels. All samples contained inhibitors with mass corresponding to TIMP-1 (28 kDa) in the THP-1 medium (leukemic monocyte cell line) used as molecular mass standard (Figure 2c ).
The muscle extracts and myoblast cell lysate produced additional bands with various molecular masses. Mass spectrometry analyses detected TIMP-1, TIMP-2 as well as TIMP-3 in the C2C12 cell lysate (data not shown).
Intracellular MMP-2 was co-localized with gelatinolytic activity
To investigate if the intracellular MMP-2 was active, in situ gelatin zymography was performed followed by immunofluorescent staining for MMP-2. MMP-2 is a potent gelatinolytic enzyme, and accordingly, intracellular gelatinolytic activity ( Figure 3A ) was found to be co-localized with MMP-2 staining ( Figure 3A-D) . In situ gelatin zymography further revealed strong activity in the periphery of muscle fibers, accompanied by punctuated activity inside the fibers in muscles from both mice ( Figure 3A and E) and human (Supplementary file Figure S2A ). There was a distinct difference in staining intensity between adjacent fibers ( Figure 3E , S2A). In longitudinally cut muscles ( Figure 3A ) prominent gelatinolytic activity was seen with the same cross-striated pattern as the MMP-2 staining ( Figure 3B ). In contrast to the immunohistochemical MMP-2 staining, no distinct gelatinolytic activity was seen in the nuclear membrane, indicating that the enzyme in this location was inactive. Addition of the metalloprotease inhibitor EDTA caused an almost complete inhibition of the gelatinolytic activity ( Figure 3F , supplementary file Figure S2B ), indicating that metalloproteases were responsible for the observed activity. The selective gelatinase inhibitor CTT2 also showed a strong inhibitory effect ( Figure 3G ), though not as complete as EDTA, supporting that MMP-2 was active inside the muscle fibers. The cysteine protease inhibitor E-64 had no apparent effect on the activity ( Figure 3H ). No activity was seen in the freeze-inhibited sections (Supplementary file Figure S2C ), indicating that there was no auto-fluorescence in the tissue.
Fast twitch type II fibers had more intracellular gelatinolytic activity than slow twitch type I fibers
In the muscle fibers we could see abundant MMP-2 staining and co-localized gelatinolytic activity in normal, healthy muscle fibers, but the intensity of both the staining and the gelatinolytic activity varied among individual fibers in the same muscle bundle. To investigate if this difference in gelatinolytic activity corresponded to muscle fiber type, we performed ATPase staining (pH 4.5 and pH 9.4) on unfixed, snap-frozen muscle tissue (from the vastus lateralis and biceps muscles) to separate type I slow twitch and type II fast twitch muscle fibers. In situ gelatin zymography was performed on serial sections from the same tissue. As snap-freezing does not preserve the morphology of the tissue as well as ZBF, the images from these experiments doesn't reveal as many details as those from analyses of ZBFfixed samples as shown in the other figures. At pH 9.4 the type II fibers show strong ATPase activity and develop a dark brown color, whereas type I fibers show weak ATPase activity and develop a light brown color. At pH 4.5 the picture is opposite (Engel and Tice, 1966) .
Comparison of the same areas in ATPase stained sections at pH 9.4 and in consecutive sections subjected to in situ gelatin zymography (Figure 4 , upper panel) showed a strong correlation between gelatinolytic activity and fiber type. Type II fibers appeared to have significantly more gelatinolytic activity than type I fibers. This was also the case with ATPase staining at pH 4.5 (Figure 4 lower panel).
Intracellular gelatinolytic activity and MMP-2 expression was reduced by physical exercise
To investigate whether increased physical exercise could affect the level of intracellular gelatinolytic activity in muscles, in situ gelatin zymography was performed on the gastrocnemius muscle from C57BL/6J mice exposed to high intensity tread mill running for five consecutive days ( Figure 5B ) and their untrained littermates ( Figure 5A ). Quantification of mean fluorescence intensity ( Figure 5E ) representing gelatinolytic activity showed a statistically significant decrease (p < 0.001) in fluorescence intensity in both type I and type II fibers of mice exposed to high intensity interval training compared to the control littermates.
To verify that MMP-2 contributed to this difference in gelatinolytic activity, the gelatinase inhibitor CTT2 was added to control sections. This showed a strong inhibitory effect in both groups (data not shown). Furthermore there was a strong correlation between intensity of MMP-2 immunofluorescent staining and level of gelatinolytic activity ( Figure 5A , B, D, E, F). The differences in MMP-2 staining intensity between trained and normal mice were also statistically significant for both type I and type II fibers (P < 0.001).
Discussion
In this study we show, by immunohistochemistry and immunogold electron microscopy, that MMP-2 is localized intracellularly in compartments other than the secretory pathways in skeletal muscle fibers. We found the enzyme concentrated, but not exclusively expressed in Z-lines of the sarcomere, in mitochondria as well as in the nuclear membrane of normal skeletal muscle fibers, but further studies are warranted to precisely determine the intracellular localizations of MMP-2. Immunohistochemical staining of MMP-2 was colocalized with gelatinolytic activity in the muscle fibers, although there were compartments with MMP-2 staining that did not reveal gelatinolytic activity, such as the nuclear membrane.
This indicates that the MMP-2 in this location was inactive. The gelatinolytic activity was almost completely inhibited by the metalloprotease inhibitor EDTA. The selective MMP-2 and MMP-9 inhibitor CTT2 (Heikkila et al., 2006 ) also had a strong inhibitory effect, although not as complete as EDTA. Immunohistochemical staining for MMP-9, the other member of the MMP gelatinase group, was negative in the muscle fibers. Also SDS-PAGE zymography of myoblast cell lysates and conditioned medium showed strong bands corresponding to masses of both pro-and active MMP-2 but no MMP-9 bands. A diffuse band corresponding to the molecular mass of mouse MMP-9 was seen in zymography gels of mouse muscle tissue extracts, and may be from stromal cells such as macrophages which are known to produce MMP-9 constitutively (Vandooren et al., 2013) . Thus, our results strongly suggest that MMP-2 was the main active gelatinase within the muscle fibers.
Real-time reverse gelatin zymography revealed that there were inhibitors of gelatinolytic enzymes present in both muscle tissue extracts, muscle cell lysates and in conditioned medium from the muscle cells with masses corresponding to TIMP-1 in the standard. The tissue extracts and cell lysates contained additional inhibitors with various molecular masses.
By mass spectrometric analyses TIMP-1, TIMP-2 and TIMP-3 were identified in some of these bands. These results indicate that there are several more MMP-inhibitors present intracellularly or at the cell membrane than in the conditioned medium.
MMP-2 is synthesized with an N-terminal signal sequence that directs the protein for secretion, and it is usually activated by MMP-14 at the cell membrane (Hadler-Olsen et al., 2011a) . Lately however, several mechanisms for intracellular recruitment and activation of the enzyme have been revealed. An alternative splice variant of MMP-2 lacking the signal sequence was recently discovered, which may account for some of the intracellular pool of the enzyme (Ali et al., 2012) . In addition, the signal sequence of MMP-2 was found to be weak, causing retention of a substantial amount of the signal sequence containing MMP-2 within the cells. These mechanisms of intracellular localization of MMP-2 were demonstrated in various cell types, among them cardiomyocytes (Ali et al., 2012) , and may cause intracellular retention of MMP-2 also within skeletal muscle fibers. Another recent publication reported an alternative MMP-2 splice variant lacking both the N-terminal signal sequence as well as the inhibitory pro-domain. This truncated and active form of the enzyme was found in the cytosolic and mitochondrial fraction of cardiomyocytes and was induced in response to oxidative stress (Lovett et al., 2012) . Upon oxidative stress, full-length MMP-2 has also been found to be activated by peroxynitrite and glutathione through modification of the cysteine residue of the enzymes inhibitory pro-domain in cardiomyocytes (Viappiani et al., 2009) . As reactive oxygen and nitrogen species are produced in skeletal muscle during contraction (Balon and Nadler, 1994; Pattwell et al., 2004; Powers et al., 2011) , the intracellular MMP-2 activity may be due to the same mode of enzyme activation. There are also studies showing that binding of MMPs to molecules such as SIBLING proteins and the alpha 2 chain of collagen type VI can induce conformational changes that dislocates the pro-domain from the active site giving an active, full-length enzyme (Fedarko et al., 2004; Freise et al., 2009 ). This suggests that MMP-2 could also be activated by binding to intracellular proteins in the skeletal muscle cells without being proteolytically processed. By mass spectrometry, we detected TIMP-2, MMP-14 and MMP-24 in the myocytes. TIMP-2 and MMP-14 are known activators of MMP-2 (Hadler-Olsen et al., 2011a) , and MMP-24 is also believed to be a potent MMP-2 activator (Llano et al., 1999) , showing that the myocytes also produce the proteins needed for proteolytic activation of MMP-2.
Along with discoveries of intracellular recruitment and activation mechanisms of MMP-2, a number of putative intracellular substrates have been identified. By processing α-actinin-1, desmin, myosin light chain-1, troponin I or titin in cardiomyocytes MMP-2 may contribute in regulation of contractile force (Sung et al., 2007a; Cauwe and Opdenakker, 2010; Ali et al., 2011) . In vitro studies have also demonstrated that MMP-2 is able to process several mitochondrial proteins such as heat shock protein 75, -90α and -90β and peroxiredoxin 5, linking the enzyme to regulation of protein folding and antioxidant activity (Cauwe and Opdenakker, 2010) . Within a muscle bundle, we found that the gelatinolytic activity was much stronger in fast twitch type II fibers than in slow twitch type I fibers as judged by
ATPase staining and gelatin in situ zymography of the same tissue. In accordance with our findings, it has previously been reported that muscles with abundance of type II fibers, express more MMP-2 at both mRNA and protein level than muscles containing mainly type I fibers (Carmeli et al., 2005; Carmeli et al., 2010) . These previous studies have looked at protein expression in muscle homogenates where the extracellular matrix and blood from the microcirculation might have contributed to the pool of MMP-2. Therefore, the sources of MMP-2, and the precise localization of the enzyme in the muscles cannot be determined from these previous studies. Fast twitch type II fibers have high levels of glycolytic enzymes (Schiaffino and Reggiani, 2011) , and a number of these, such as enolase-α, -β and γ, fructosebisphosphate, aldolase A and GAPDH, are identified as putative intracellular MMP-2
substrates (Cauwe and Opdenakker, 2010) . Proteolytic processing of these enzymes by MMP-2, could explain why we detected more gelatinolytic activity in the glycolytic type II fibers than in oxidative type I fibers, and suggest a role of MMP-2 in regulation of carbohydrate metabolism.
We found a statistically significant decrease in intracellular gelatinolytic activity in muscles from mice exposed to high intensity interval training. In contrast to our results, increased levels of MMP-2 in muscles have previously been reported after 10 days of endurance exercise in humans, and after two to eight weeks of high-intensity training in rats (Carmeli et al., 2005; Rullman et al., 2009; Carmeli et al., 2010; Deus et al., 2012) . Furthermore, a study by Yeghiazaryan et al. found gelatinolytic activity in the nucleus of skeletal muscles in rats which increased after 5 days of repeated physical training (Yeghiazaryan et al., 2012) . The discrepancy between these studies and ours may be due to species differences, as we have studied mouse muscle, and not rat. The relative intensity and duration of the exercise regiments may also contribute to different results, as well as differences in experimental conditions and detection methods. Except the study by Yeghiazaryan et al., these previous studies have not discriminated between intracellular and extracellular MMP-2 in the muscles, so the apparent discrepancy between our results and previous results may be due to increased MMP-2 secretion along with less intracellular retention during high-intensity training. This is in line with studies from cardiomyocytes, where ischemia-reperfusion injuries caused increased MMP-2 levels in the coronary effluents which were accompanied by a depletion of intracellular MMP-2 levels (Cheung et al., 2000) . Ischemia-reperfusion injuries in hearts have furthermore been shown to cause a rapid induction of MMP-2 transcription, which may quickly re-establish intracellular MMP-2 levels (Alfonso-Jaume et al., 2006). The reduced levels of MMP-2 and gelatinolytic activity that we measured in muscles from trained mice could therefore be due to the fact that they were sacrificed only minutes after the last round of exercise, before the MMP-2 levels had been reestablished. If contraction induces activation of intracellular MMP-2, this could be a control mechanism to avoid harmful over-activity of the enzyme inside the muscle cell, or due to increased need of extracellular MMP-2 upon muscle contraction.
Taken together our results demonstrate intracellular localization and activity of MMP-2 in skeletal muscle fibers, which is most prominent in type II fast twitch fibers. The amount and activity of the enzyme was affected by physical activity. The specific intracellular functions of the enzyme can so far only be speculated. MMPs have long been regarded as appealing drug targets in various diseases, especially in cancer patients, where broad spectrum MMPinhibitors have been tested in clinical trials. Musculoskeletal pain has been a frequent side effect reported after prolonged use of such inhibitors (Zucker et al., 2000; Brinckerhoff and Matrisian, 2002; Coussens et al., 2002) , and suggests that MMPs are implicated in muscular physiology. Thus to be able to develop safe and predictably working MMP-inhibitors, and to expand our understanding of the physiology of skeletal muscles, further studies of these new aspects of MMP-2 biology are warranted. MMP-2 staining is seen as brown color, whereas nuclei are stained blue by hematoxylin. In C-F representative images of immunogold electron microscopic MMP-2 staining of mouse gastrocnemius muscle is shown, MMP-2 staining is seen as dark spots. Figure 1C demonstrates concentration of the enzyme in Z-bands (Z) in cross section, in (D) labeling is seen surrounding myofibrils, image (E) shows concentration of labeling in mitochondria (M) and image (F) at the nuclear membrane. and MMP-2 as described above. 
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